Syntone Ventures LLC is 10% Owner at Outlook Therapeutics, Inc. (OTLK). They have made 2 open-market trades across 1 company since 2020, most recently 2024-04-15.
CIK 0001814394
2 open-market purchases totalling $5.0M since 2020, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| OTLK | 1,071,429 | $522K |
Shares reported on the most recent Form 4, priced at the 2024-04-17 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.